Fiscal Wizard · Single-issue tearsheet

MEDP / May 12, 2026 Run #8

MEDP

Medpace Holdings, Inc.

Diagnostics & Research

Composite verdict

D 33.0 / 100

Above-average fundamentals, weak technicals.

Industry rank 5th of 14 in Diagnostics & Research

industry=Diagnostics & Research

Fundamentals Above average

65.4 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 34 metrics shown.

Strongest
Weakest
FCF Margin 100
OCF to Net Income 0
Return on Assets 100
Earnings Yield 7
Return on Capital Employed 100
Greenblatt EY 14

Technicals Weak

0.6 / 100

Bearish setup leads (Relative Strength vs SPY, Fibonacci Retracement, Trendline Break); bulls voided by gates. · 26 signals shown.

Strongest
Weakest
OBV Divergence 50
Relative Strength vs SPY 0
Head and Shoulders 43
Fibonacci Retracement 0
Pin Bar 42
Trendline Break 11

Risk Gates

2 blocking 3 caution

2 gates blocking, 10 signals voided.

  • MA Crossover voids Volume Climax, Declining Volume +8
  • Regime Filter voids Volume Climax, Declining Volume +8
  • Current Ratio caution band
  • Sloan Ratio caution band

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for MEDP.